Reduced levels of dermcidin-derived peptides has been detected in the sweat of patients with atopic dermatitis in association with an impaired cutaneous antimicrobial defense [49], while the increased expression of dermcidin has been demonstrated in lung, prostate and pancreatic cancer cells [50,51]. This evidence concerns the gene DCD and pancreatic neoplasm.